Table 1. Expression profiles of 13 lncRNAs in stage IV CRC patients compared with matched liver metastases.

	Liver metastases / colorectal carcinoma
	Fold change	P value	AUC	95% CI
CCAT1	0.4	0.1004	0.59	0.49 - 0.69
GAS5	0.4	0.0038	0.68	0.58 - 0.77
H19	1.0	0.0314	0.64	0.54 - 0.73
IGF2-AS	−0.5	0.3582	0.59	0.49 - 0.69
lncRNA-LET	−0.1	0.5322	0.57	0.47 - 0.67
MALAT1	0	0.7225	0.58	0.48 - 0.68
MEG3	−0.3	0.0003	0.73	0.64 - 0.82
MIR17HG	−0.2	0.3072	0.57	0.46 - 0.67
p15AS	0.2	0.7194	0.58	0.48 - 0.68
PVT1	0.2	0.2114	0.54	0.44 - 0.64
UCA1	0.2	0.4989	0.52	0.42 - 0.62
XIST	−0.6	0.3485	0.54	0.44 - 0.64
Yiya	0.6	0.0272	0.63	0.53 - 0.72

CRC, colorectal cancer

AUC, area under the receiver operating characteristic curve

CI, confidence interval